Recent whole-genome and -exome sequencing have identified recurrent human POT1 mutations in chronic lymphocytic leukaemia33, 34, familial melanoma (FM)35, 36, glioma37, cardiac angiosarcoma38 and mantle cell lymphoma39, making it the most commonly mutated shelterin component in cancer. Here, POT1 is linked to cancer.